IFN-α is currently used for the treatment for chronic HCV infection, HBV infection, and many malignant tumors, including hepatitis B, melanoma, hairy cell leukemia, and non-Hodgkin's lymphoma. The gene discussed is IFNA1; the disease is cancer.